Evidence map›Paper›PMID 42045563›Full record

ReviewNature protocols2026

Whole-mouse immunolabeling at cellular resolution for comprehensive 3D atlases.

Hongcheng Mai, Yuewei Wang, Yu Zhu, Yin Zhao, Ying Chen, Luciano Hoeher, Rami Al-Maskari, Jie Luo, Ali Erturk

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hongcheng Mai *Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Yuewei Wang *Department of Industrial and Molecular Pharmaceutics, Purdue University, West Lafayette, IN, USA.ORCID http://orcid.org/0009-0004-7686-2376
Yu Zhu *Department of Industrial and Molecular Pharmaceutics, Purdue University, West Lafayette, IN, USA.
Yin ZhaoDepartment of Industrial and Molecular Pharmaceutics, Purdue University, West Lafayette, IN, USA.
Ying ChenInstitute for Intelligent Biotechnologies (iBIO), Helmholtz Center Munich, Neuherberg, Germany.
Luciano HoeherInstitute for Intelligent Biotechnologies (iBIO), Helmholtz Center Munich, Neuherberg, Germany.
Rami Al-MaskariInstitute for Intelligent Biotechnologies (iBIO), Helmholtz Center Munich, Neuherberg, Germany.
Jie LuoDepartment of Industrial and Molecular Pharmaceutics, Purdue University, West Lafayette, IN, USA. jieluo@purdue.edu.ORCID http://orcid.org/0009-0004-4291-6823
Ali ErturkInstitute for Intelligent Biotechnologies (iBIO), Helmholtz Center Munich, Neuherberg, Germany.ORCID http://orcid.org/0000-0001-5163-5100

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mapping complex biological systems and tracking disease progression at high resolution across the entire mammalian body has remained technically challenging. Here, to address this, we present wildDISCO (immunolabeling of wild-type mice and DISCO clearing), a comprehensive protocol for whole-body immunolabeling, optical clearing and imaging of mice at cellular resolution using standard IgG antibodies. This protocol optimizes tissue permeabilization using cyclodextrin as a potent enhancer of cholesterol extraction and membrane permeabilization, enabling deep antibody penetration across all organs. We detail procedures for sample preparation, tissue decolorization and decalcification, whole-body immunostaining, clearing, and subsequent 3D imaging, virtual reality visualization and whole-mouse atlas construction. The method allows comprehensive mapping of neuronal, vascular, lymphatic and immune systems, as well as systemic studies in disease models, including cancer and microbiome-host interaction studies. We anticipate that wildDISCO will serve as a broadly applicable platform for generating whole-body cellular atlases, enabling systems-level investigations of health and disease. Only standard immunohistochemistry facilities are required, but successful implementation may require initial technical training, particularly for researchers with limited prior experience in tissue clearing or 3D imaging workflows. From start to finish, the procedure takes 4 weeks.

Indexed as

Imaging, Three-DimensionalImmunohistochemistryWhole Body ImagingAnimalsMice

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.